Research Topics
Species | Mark J SarnakSummaryAffiliation: Tufts-New England Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Cystatin C and aging successMark J Sarnak
Department of Medicine, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Arch Intern Med 168:147-53. 2008..To our knowledge, the effect of kidney function on successful aging has not been examined...
Cardiovascular complications in chronic kidney diseaseMark J Sarnak
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 41:11-7. 2003..Treatment of both traditional and uremia-related risk factors should be initiated in the earlier stages of CKD. Additional clinical trials with a goal to reduce CVD are urgently needed in CKD...
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease studyMark J Sarnak
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 142:342-51. 2005..Hypertension is a risk factor for progression of chronic kidney disease. The optimal blood pressure to slow progression is unknown...
Waist-to-hip ratio and body mass index as risk factors for cardiovascular events in CKDEssam F Elsayed
Department of Medicine, Tufts Medical Center, Boston, MA, USA
Am J Kidney Dis 52:49-57. 2008..Waist-to-hip ratio (WHR) is less influenced by muscle and bone mass than body mass index (BMI). We compared WHR and BMI as risk factors for cardiac events (myocardial infarction and fatal coronary disease) in persons with CKD...
Waist-to-hip ratio, body mass index, and subsequent kidney disease and deathEssam F Elsayed
Nephrology Research Center, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 52:29-38. 2008..Chronic kidney disease (CKD) and obesity are important public health concerns. We examined the association between anthropomorphic measures and incident CKD and mortality...
Factors associated with lipoprotein(a) in chronic kidney diseaseKatrin Uhlig
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 45:28-38. 2005....
The Framingham predictive instrument in chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 50:217-24. 2007..We sought to determine the utility of the Framingham equations in individuals with chronic kidney disease (CKD)...
Chronic kidney disease in octogenariansShani Shastri
Tufts Medical Center, Boston, MA 02111, USA
Clin J Am Soc Nephrol 6:1410-7. 2011..There are limited data on the prevalence of chronic kidney disease (CKD) and its clinical importance in the very old. We examined the prevalence of CKD in octogenarians and its association with cardiovascular disease (CVD)...
Relationship of phosphorus and calcium-phosphorus product with mortality in CKDVandana Menon
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA, USA
Am J Kidney Dis 46:455-63. 2005....
Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney diseaseVandana Menon
Department of Medicine, Division of Clinical Care Research, Tufts-New England Medical Center, Boston, MA, USA
Am J Kidney Dis 42:44-52. 2003..CRP levels are independently associated with serum albumin level and CVD prevalence. Inflammation may be involved in the pathophysiological state of malnutrition and CVD in the earlier stages of predominantly nondiabetic kidney disease...
Obesity and change in estimated GFR among older adultsIan H De Boer
Division of Nephrology, University of Washington, Seattle, WA 98195, USA
Am J Kidney Dis 54:1043-51. 2009..Obesity assessed in midlife has been associated with chronic kidney disease...
Kidney function and mortality in octogenarians: Cardiovascular Health Study All StarsShani Shastri
Division of Nephrology, University of Texas Southwestern, Dallas, Texas 75390, USA
J Am Geriatr Soc 60:1201-7. 2012..To examine the association between kidney function and all-cause mortality in octogenarians...
The relationship between nontraditional risk factors and outcomes in individuals with stage 3 to 4 CKDDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 51:212-23. 2008..Chronic kidney disease is associated with increased risk for cardiovascular disease and mortality. Both traditional and nontraditional cardiovascular disease risk factors may contribute...
Depression and cognitive function in maintenance hemodialysis patientsBrian T Agganis
Division of Nephrology, Tufts Medical Center, Boston, MA, USA
Am J Kidney Dis 56:704-12. 2010..Both depression and cognitive impairment are common in hemodialysis patients, are associated with adverse clinical outcomes, and place an increased burden on health care resources...
Role of adipose tissue in determining muscle mass in patients with chronic kidney diseaseCarmen Castaneda-Sceppa
Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts 02111, USA
J Ren Nutr 17:314-22. 2007..Arm muscle area was used as an indicator of muscle mass...
Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts, USA
J Am Soc Nephrol 16:3411-7. 2005..43; P = 0.07). HbA(1c) is associated with increased mortality in nondiabetic kidney disease. Hyperglycemia may be a potential therapeutic target and HbA(1c) may be important as a risk stratification tool in this high-risk population...
Uric acid and long-term outcomes in CKDMagdalena Madero
Department of Medicine, Division of Nephrology, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
Am J Kidney Dis 53:796-803. 2009..Hyperuricemia is prevalent in patients with chronic kidney disease (CKD); however, data are limited about the relationship of uric acid levels with long-term outcomes in this patient population...
Relationship between homocysteine and mortality in chronic kidney diseaseVandana Menon
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, MA, USA
Circulation 113:1572-7. 2006..Prior studies demonstrating an association between tHcy and CVD risk may have inadequately adjusted for the confounding effects of kidney function...
Cystatin C as a risk factor for outcomes in chronic kidney diseaseVandana Menon
Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 147:19-27. 2007....
Retinal microvascular signs and disability in the Cardiovascular Health StudyDae Hyun Kim
Division of Gerontology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA
Arch Ophthalmol 130:350-6. 2012..To study the associations of retinal microvascular changes, which are associated with systemic conditions and cognitive decline, with disability in performing activities of daily living (ADL)...
Anemia as a risk factor for kidney function decline in individuals with heart failureNisha Bansal
Division of Nephrology, Tufts New England Medical Center, Boston, Massachusetts, USA
Am J Cardiol 99:1137-42. 2007..03 to 1.31) of rapid decrease (p for interaction <0.001). In conclusion, anemia is associated with a rapid decrease in kidney function in patients with heart failure, particularly in those with underlying CKD...
Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney diseasePanagiotis T Vlagopoulos
Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
J Am Soc Nephrol 16:3403-10. 2005..66) for all-cause mortality. Anemia was not a risk factor for any outcome in those without CKD (P > 0.2 for all outcomes). In persons with diabetes, anemia is primarily a risk factor for adverse outcomes in those who also have CKD...
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) StudyVandana Menon
Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA, USA
Am J Kidney Dis 53:208-17. 2009..We examined the effect of a very low-protein diet on the development of kidney failure and death during long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study...
C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 68:766-72. 2005..High CRP, but not serum albumin, is a risk factor for cardiovascular mortality. These results suggest that high CRP and hypoalbuminemia provide prognostic information independent of each other in CKD...
Homocysteine in chronic kidney disease: Effect of low protein diet and repletion with B vitaminsVandana Menon
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 67:1539-46. 2005..There is insufficient evidence to suggest that low tHcy is associated with poor nutritional status in the MDRD Study cohort. B vitamins and GFR, but not dietary protein, are the major determinants of tHcy in this patient population...
Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney diseaseJill Melendez Young
Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA
Clin J Am Soc Nephrol 4:1115-20. 2009..This dimethylated amino acid accumulates in chronic kidney disease and may be involved in the pathophysiology of cardiovascular disease (CVD) in this population...
Association between baseline kidney function and change in CRP: an analysis of the cardiovascular health studyDena E Rifkin
Division of Nephrology, University of California, San Diego and Veterans Affair Hospital, San Diego, CA 92093 9111, USA
Nephron Clin Pract 115:c114-21. 2010..In cross-sectional analyses, C-reactive protein (CRP) levels are inversely related to levels of kidney function. The relationship between kidney function and subsequent changes in CRP is unknown...
Level of kidney function as a risk factor for cardiovascular outcomes in the elderlyGuruprasad Manjunath
Department of Medicine, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts, USA
Kidney Int 63:1121-9. 2003..A linear model best described the relationship between GFR and CVD. CONCLUSION: The level of GFR is an independent risk factor for CVD, de novo CVD, and all-cause mortality in the elderly...
Cystatin C concentration as a risk factor for heart failure in older adultsMark J Sarnak
Tufts-New England Medical Center, Boston, Massachusetts, USA
Ann Intern Med 142:497-505. 2005..For a full list of participating Cardiovascular Health Study investigators and institutions, see http://www.chs-nhlbi.org...
Cystatin C concentration as a predictor of systolic and diastolic heart failureAndrew Moran
Department of Medicine, University of California at San Francisco, San Francisco, California, USA
J Card Fail 14:19-26. 2008..We hypothesized that kidney dysfunction would predict diastolic HF (DHF) better than systolic HF (SHF) in the Cardiovascular Health Study...
Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study)Joachim H Ix
Department of Medicine, University of California San Diego, USA
J Am Coll Cardiol 54:1176-84. 2009..This study sought to determine the association of chronic kidney disease (CKD) with high ankle brachial index (ABI) measurement and to compare its strength with that of CKD with a low ABI...
Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health StudyChristopher Keller
Department of Medicine, University of California San Francisco, San Francisco, CA, USA
Nephrol Dial Transplant 25:119-24. 2010..The objective of this study was to determine whether elevated markers of inflammation are independently associated with longitudinal kidney function decline...
Cardiovascular disease and subsequent kidney diseaseEssam F Elsayed
Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Campus Box 391, Boston, MA 02111
Arch Intern Med 167:1130-6. 2007..Chronic kidney disease is a risk factor for cardiovascular disease (CVD); however, it is uncertain if CVD is a risk factor for progression or development of kidney disease...
Apolipoprotein E and kidney function in older adultsRebecca Kurnik Seshasai
Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, MA 02111, USA
Clin Nephrol 78:174-80. 2012..We evaluated the associations of apolipoprotein E alleles with kidney function among older adults in the cardiovascular health study (CHS)...
Predictors of sudden cardiac death: a competing risk approach in the hemodialysis studyShani Shastri
Division of Nephrology, Tufts Medical Center, 800 Washington Street, Box 391, Boston, MA 02111, USA
Clin J Am Soc Nephrol 7:123-30. 2012..The study objective was to identify predictors associated with various causes of death in the Hemodialysis (HEMO) Study and to develop a prediction model for SCD using a competing risk approach...
Effect of dietary protein restriction on the progression of kidney disease: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) StudyAndrew S Levey
Division of Nephrology, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, MA 02111, USA
Am J Kidney Dis 48:879-88. 2006..CONCLUSION: The efficacy of a 2- to 3-year intervention of dietary protein restriction on progression of nondiabetic kidney disease remains inconclusive. Future studies should include a longer duration of intervention and follow-up...
Kidney function, electrocardiographic findings, and cardiovascular events among older adultsBryan Kestenbaum
Division of Nephrology, Harborview Medical Center, University of Washington, Seattle, WA 98104 2499, USA
Clin J Am Soc Nephrol 2:501-8. 2007..Associations seemed stronger for participants with CKD; however, no significant interactions were detected. Resting electrocardiographic abnormalities are common in CKD and independently predict future clinical CV events in this setting...
Body mass index and mortality in CKDMagdalena Madero
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 50:404-11. 2007..Data are limited on the relationship of BMI with mortality in patients in the earlier stages of chronic kidney disease (CKD)...
Kidney disease as a risk factor for recurrent cardiovascular disease and mortalityDaniel E Weiner
Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 44:198-206. 2004..CONCLUSION: The presence of CKD in a community-based population with preexisting CVD is associated with an increased risk for recurrent CVD outcomes. This increased risk persists after adjustment for traditional CVD risk factors...
Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studiesDaniel E Weiner
Division of Nephrology, Department of Clinical Care Research, Tufts-New England Medical Center, Boston, Massachusetts, USA
J Am Soc Nephrol 15:1307-15. 2004..It is hypothesized that this effect may be due to more frequent or more severe subclinical vascular disease secondary to hypertension or diabetes in black individuals...
Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Tufts-New England Medical Center, 750 Washington Street, Box 391, Boston, MA 02111, USA
J Am Soc Nephrol 16:1803-10. 2005..15 [95% CI, 2.62 to 6.56] and 3.92 [95% CI, 2.05 to 7.48]; P = 0.02 and 0.01 for interaction term, respectively). The combination of anemia and LVH in CKD identifies a high-risk population...
Serum bicarbonate and long-term outcomes in CKDVandana Menon
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 56:907-14. 2010..A low serum bicarbonate level is prevalent in chronic kidney disease (CKD); however, its relationship to long-term outcomes is unclear...
Rapid kidney function decline and mortality risk in older adultsDena E Rifkin
Division of Nephrology, Tufts Medical Center, 750 Washington St, Box 391, Boston, MA 02111, USA
Arch Intern Med 168:2212-8. 2008..It remains unknown, however, whether longitudinal declines in kidney function are independently associated with increased cardiovascular and all-cause mortality in older adults...
CKD classification based on estimated GFR over three years and subsequent cardiac and mortality outcomes: a cohort studyDaniel E Weiner
Division of Nephrology, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
BMC Nephrol 10:26. 2009..It is unknown whether defining chronic kidney disease (CKD) based on one versus two estimated glomerular filtration rate (eGFR) assessments changes the prognostic importance of reduced eGFR in a community-based population...
Alcohol consumption and kidney function decline in the elderly: alcohol and kidney diseaseVandana Menon
Division of Nephrology, Tufts Medical Center, Boston, MA, USA
Nephrol Dial Transplant 25:3301-7. 2010..Alcohol consumption appears to be protective for cardiovascular disease; however, its relationship with kidney disease is unclear...
Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney diseaseVarun Chawla
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Clin J Am Soc Nephrol 5:1582-7. 2010..Dyslipidemia confers a paradoxical survival advantage in patients with kidney failure. Data are limited in the earlier stages of chronic kidney disease (CKD)...
Association of visceral and subcutaneous adiposity with kidney functionJill A Young
Tufts New England Medical Center, Boston, Massachusetts, USA
Clin J Am Soc Nephrol 3:1786-91. 2008..Visceral (VAT) and subcutaneous adipose tissue (SAT) may confer differential metabolic risk profiles. The relations of VAT and SAT were analyzed with CKD as estimated by creatinine- and cystatin-based estimating equations...
Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Box 391, Tufts New England Medical Center, Boston, MA 02111, USA
J Am Soc Nephrol 18:960-6. 2007..CKD and elevated SBP are independent risk factors for incident stroke. In CKD, individuals with the lowest BP are at increased risk for stroke. This pattern is not seen in the general population...
Cognitive function and dialysis adequacy: no clear relationshipLena M Giang
Tufts Medical Center, Boston, MA 02111, USA
Am J Nephrol 33:33-8. 2011..The impact of dialysis dose on cognitive function remains uncertain, particularly in the current era of increased dialysis dose and flux...
Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular diseaseDaniel E Weiner
Division of Nephrology, Department of Internal Medicine, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 48:392-401. 2006..Concurrently, CVD may promote CKD, resulting in a vicious cycle. We evaluated this hypothesis by exploring whether CKD and CVD have an additive or synergistic effect on future cardiovascular and mortality outcomes...
Adiponectin and mortality in patients with chronic kidney diseaseVandana Menon
Tufts New England Medical Center, Division of Nephrology, 750 Washington Street, NEMC 391, Boston, MA 02111, USA
J Am Soc Nephrol 17:2599-606. 2006..Further studies are necessary to confirm this association and to elucidate the underlying mechanisms...
The risk of infection-related hospitalization with decreased kidney functionLorien S Dalrymple
Department of Medicine, University of California Davis, USA
Am J Kidney Dis 59:356-63. 2012..Moderate kidney disease may predispose to infection. We sought to determine whether decreased kidney function, estimated by serum cystatin C level, was associated with the risk of infection-related hospitalization in older individuals...
Filtration markers may have prognostic value independent of glomerular filtration rateNavdeep Tangri
Department of Medicine, Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
J Am Soc Nephrol 23:351-9. 2012..trace protein and cystatin C seem to provide more consistent prognostic information than creatinine...
Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA)Shani Shastri
Tufts Medical Center, 800 Washington St, Boston, MA 02111, USA
Am J Kidney Dis 57:832-40. 2011..The growing burden and morbidity of chronic kidney disease (CKD) warrant effective strategies for identifying those at increased risk. We examined the association of cystatin C level and albuminuria with the development of CKD stage 3...
Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease StudyMark J Sarnak
New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Kidney Int 62:2208-15. 2002..In vitro and in vivo data suggest that markers of inflammation and nutritional status may be risk factors for the progression of chronic kidney disease...
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the communityGuruprasad Manjunath
Division of Nephrology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 41:47-55. 2003..13) for ASCVD, de novo ASCVD, and recurrent ASCVD, respectively. A nonlinear model did not fit the data better than a linear model. CONCLUSIONS: The level of GFR is an independent risk factor for ASCVD and de novo ASCVD in the ARIC study...
β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO StudyNavdeep Tangri
Division of Nephrology, Department of Medicine, Seven Oaks General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada
Am J Kidney Dis 58:939-45. 2011..Although the efficacy of β-blockers for the prevention of sudden cardiac death has been proven in the general population, little evidence exists in patients with kidney failure...
Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA)Anh L Bui
Department of Medicine, University of California, San Francisco, CA, USA
Am J Kidney Dis 53:389-98. 2009..We therefore explored whether serum cystatin C level is associated with carotid intima-media thickness (IMT) in ambulatory adults without clinical heart disease...
Chronic kidney disease and the risk of end-stage renal disease versus deathLorien S Dalrymple
Department of Medicine, University of California Davis, 4150 V Street, 3500 PSSB, Sacramento, CA 95817, USA
J Gen Intern Med 26:379-85. 2011..Among older adults with chronic kidney disease (CKD), the comparative event rates of end-stage renal disease (ESRD) and cause-specific death are unknown...
Creatinine-based formulae for estimating glomerular filtration rate: is it time to change to chronic kidney disease epidemiology collaboration equation?Magdalena Madero
Division of Nephrology, Department of Medicine, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico
Curr Opin Nephrol Hypertens 20:622-30. 2011....
Homocysteine lowering and cardiovascular disease risk: lost in translationJeremy Marcus
Department of Medicine, Division of Nephrology, Tufts New England Medical Centre, Boston, Massachusetts 02111, USA
Can J Cardiol 23:707-10. 2007..Several more interventional trials are ongoing, but the available data thus far do not support screening for or treatment of hyperhomocysteinemia...
Kidney disease, Framingham risk scores, and cardiac and mortality outcomesDaniel E Weiner
Division of Nephrology, Tufts New England Medical Center, Boston, Mass 02111, USA
Am J Med 120:552.e1-8. 2007..The Framingham equations were developed to predict incident coronary heart disease. It remains unknown how the presence of chronic kidney disease affects their performance...
Cardiovascular disease and cognitive function in maintenance hemodialysis patientsDaniel E Weiner
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 58:773-81. 2011....
Update on cystatin C: new insights into the importance of mild kidney dysfunctionMichael G Shlipak
Department of Medicine, University of California, San Francisco, California 94121, USA
Curr Opin Nephrol Hypertens 15:270-5. 2006..Studies have questioned, however, whether cystatin C is predominantly a measure of kidney function. This review summarizes the research literature on cystatin C...
Subcortical cognitive impairment in dialysis patientsArema A Pereira
Department of Medicine, Division of Nephrology, Tufts New England Medical Center, Boston, MA 02111, USA
Hemodial Int 11:309-14. 2007..These results suggest that, despite relatively normal MMSE scores, mild cognitive impairment may be prevalent in hemodialysis patients. The pattern of cognitive dysfunction is primarily subcortical in nature...
Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunctionDouglas D Gregory
Division of Clinical Decision Making, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Am J Cardiol 92:1300-5. 2003....
Hematocrit and left ventricular mass: the Framingham Heart studyManish G Amin
Division of Clinical Care Research, Department of Medicine, Tufts-New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 43:1276-82. 2004..The clinical importance of these findings remains unknown...
Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patientsCindy X Huang
Division of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts 02111, USA
Kidney Int 77:624-9. 2010..These studies show that body composition in end-stage renal disease bears a complex relationship to all-cause mortality...
Albuminuria, cognitive functioning, and white matter hyperintensities in homebound eldersDaniel E Weiner
Division of Nephrology, Tufts Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 53:438-47. 2009..Albuminuria, a kidney marker of microvascular disease, may herald microvascular disease elsewhere, including in the brain...
Serum cystatin C as a marker of glomerular filtration rateMagdalena Madero
Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts, USA
Curr Opin Nephrol Hypertens 15:610-6. 2006..SUMMARY: Cystatin C shows promise as an alternative to serum creatinine but several important questions remain before it can be recommended for use in clinical practice...
Cognitive function in dialysis patientsArema A Pereira
Department of Medicine, Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 45:448-62. 2005..We explore potential measures to reduce cognitive impairment in this population. We conclude that additional research is needed in this area...
Homocysteine, cysteine, and B vitamins as predictors of kidney disease progressionMark J Sarnak
New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 40:932-9. 2002..Elevated total homocysteine (tHcy) levels and low B vitamin levels are risk factors for atherosclerosis, but have not been evaluated sufficiently as risk factors for the progression of kidney disease...
Managing dyslipidemia in chronic kidney diseaseDaniel E Weiner
Division of Nephrology, Tufts-New England Medical Center, Boston, Massachusetts, USA
J Gen Intern Med 19:1045-52. 2004..There are 3 ongoing randomized controlled trials that are assessing the effect of statin therapy on CVD outcomes. These studies will hopefully provide definitive answers as to the appropriate treatment of dyslipidemia in CKD...
Cognitive function in chronic kidney diseaseMagdalena Madero
Department of Medicine, Tufts New England Medical Center, Boston, Massachusetts, USA
Semin Dial 21:29-37. 2008..Given the high prevalence of cognitive impairment in all stages of CKD, additional studies are needed to evaluate potential risk factors and treatments in this vulnerable population...
Traditional cardiac risk factors in individuals with chronic kidney diseaseKatrin Uhlig
Division of Nephrology, Department of Medicine, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Semin Dial 16:118-27. 2003..Treatment recommendations are provided using evidence available from populations with CKD or evidence extrapolated from the general population when there are insufficient data on individuals with CKD...
The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: a high-risk combinationVandana Menon
Division of Nephrology, Tufts-New England Medical Center, Boston, MA 02111, USA
Am J Kidney Dis 45:223-32. 2005
Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndromeMarcelo C Batista
Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA, USA
Metabolism 53:1255-61. 2004....
Recent trends in hospital management practices and prognosis after acute myocardial infarction in patients with kidney diseaseVandana Menon
Department of Medicine, Division of Nephrology, Tufts University School of Medicine/New England Medical Center, Boston, Massachusetts, USA
Am J Cardiol 94:1290-3. 2004....
Anemia as a risk factor for cardiovascular disease in The Atherosclerosis Risk in Communities (ARIC) studyMark J Sarnak
Division of Nephrology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
J Am Coll Cardiol 40:27-33. 2002..We investigated whether the presence of anemia is a risk factor for cardiovascular disease (CVD) outcomes in the general population...
How can the cardiac death rate be reduced in dialysis patients?Guruprasad Manjunath
Division of Nephrology, Department of Medicine, New England Medical Center, Boston, Massachusetts 02111, USA
Semin Dial 15:18-20. 2002
Management of intradialytic hypertension: the ongoing challengeJoline Chen
Division of Nephrology, Department of Medicine, Tufts-New England Medical Center, Boston, Massachusetts 02111, USA
Semin Dial 19:141-5. 2006..We conclude that additional epidemiologic, basic science, and interventional studies are needed to further elucidate the prevalence, prognostic importance, pathophysiology, and potential treatment of intradialytic hypertension...
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney diseaseMichael G Shlipak
San Francisco Veterans Affairs Medical Center and University of California, San Francisco, San Francisco, California 94121, USA
Ann Intern Med 145:237-46. 2006..73 m2)...
Kidney function and mortality among patients with left ventricular systolic dysfunctionNadia A Khan
Division of Internal Medicine, University of British Columbia, Department of Medicine, 620 B, 1081 Burrard Street, Vancouver, BC, Canada, V6Z 1Y6
J Am Soc Nephrol 17:244-53. 2006..Rate of decline in kidney function is a strong predictor of increased mortality in this population, independent of worsening heart failure and baseline kidney function...
Cystatin-C and inflammatory markers in the ambulatory elderlyMichael G Shlipak
General Internal Medicine Section, San Francisco Veterans Affairs Medical Center and Department of Medicine, University of California, San Francisco, Calif 94121, USA
Am J Med 118:1416. 2005..We compared cystatin-C, a novel marker of renal function, with creatinine and estimated glomerular filtration rate (eGFR) as predictors of C-reactive protein and fibrinogen levels...
Microalbuminuria: a marker of cardiovascular riskDaniel E Weiner
Am J Kidney Dis 42:596-8. 2003
Evidence for increased cardiovascular disease risk in patients with chronic kidney diseaseJosef Coresh
Welch Center for Prevention, Epidemiology and Clinical Research, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA
Curr Opin Nephrol Hypertens 13:73-81. 2004....
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventionMark J Sarnak
Hypertension 42:1050-65. 2003
Cystatin-C and mortality in elderly persons with heart failureMichael G Shlipak
General Internal Medicine Section, Veterans Affairs Medical Center, 4150 Clement Street, University of California San Francisco, San Francisco, CA 94121, USA
J Am Coll Cardiol 45:268-71. 2005..We sought to evaluate cystatin-C, a novel measure of renal function, as a predictor of mortality in elderly persons with heart failure (HF) and to compare it with creatinine...
Relationship of uric acid with progression of kidney diseaseMichel Chonchol
Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Denver, CO 80262, USA
Am J Kidney Dis 50:239-47. 2007..Uric acid levels are increased in patients with kidney dysfunction. We tested the hypothesis that uric acid may be associated with kidney disease progression...
Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO StudyJames A Delmez
Washington University, St Louis, MO, USA
Am J Kidney Dis 47:131-8. 2006....
Kidney function as a predictor of noncardiovascular mortalityLinda F Fried
VA Pittsburgh Healthcare System and Renal Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15240, USA
J Am Soc Nephrol 16:3728-35. 2005..Kidney function predicts noncardiovascular mortality from multiple causes in the elderly. Further research is needed to understand the mechanisms and evaluate interventions to reduce the high mortality rate in chronic kidney disease...
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and PreventionMark J Sarnak
Circulation 108:2154-69. 2003
Cystatin C and the risk of death and cardiovascular events among elderly personsMichael G Shlipak
General Internal Medicine Section, Veterans Affairs Medical Center, University of California, San Francisco, USA
N Engl J Med 352:2049-60. 2005..We compared creatinine and cystatin C levels as predictors of mortality from cardiovascular causes and from all causes in the Cardiovascular Health Study, a cohort study of elderly persons living in the community...
Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) StudyBrad C Astor
Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Am Heart J 151:492-500. 2006..Mildly to moderately decreased kidney function is far more common and also is associated with an elevated prevalence of anemia and CHD risk. Recent data suggest an even higher risk of CHD when both conditions are present...
Research Grants
- CARDIOVASCULAR RISK FACTORS--CHRONIC RENAL INSUFFICIENCYMark Sarnak; Fiscal Year: 2004..The proposed L training program and research project will prepare him for a career as an independent investigator. ..
- Cardiac Risk Factors in Chronic Kidney DiseaseMark Sarnak; Fiscal Year: 2006..Evaluating the importance of traditional and non-traditional risk factors in CKD is essential in that it will focus attention on the most important cardiac risk factors in this population. ..
- Cognition and Vascular Disease in Dialysis PatientsMark Sarnak; Fiscal Year: 2006..Evaluating the prevalence of, as well as potential risk factors for, cognitive impairment may lead to intervention trials to reduce the burden of cognitive impairment in this patient population. ..
- Chronic Kidney Disease, Vascular Disease and AgingMark Sarnak; Fiscal Year: 2007..Training future investigators in POR will be essential to reduce the burden of CKD in the future. ..
